{"title":"【小儿静脉注射免疫球蛋白的适应症】。","authors":"V Popescu, D Bleahu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Current techniques allow the manufacture of intravenous immunoglobulin that fully retain their antibody content and function. Immunoglobulins have been show to be effective therapy for immune thrombocytopenia, neonatal allo(iso)immune thrombocytopenia, agammaglobulinemia, acquired immunodeficiency., premature neonates, burn patients, prophylaxis and treatment of infection in high risk and other conditions.</p>","PeriodicalId":77318,"journal":{"name":"Pediatrie (Bucharest, Romania)","volume":"41 1","pages":"37-45"},"PeriodicalIF":0.0000,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The indications for intravenous immunoglobulins in pediatric practice].\",\"authors\":\"V Popescu, D Bleahu\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Current techniques allow the manufacture of intravenous immunoglobulin that fully retain their antibody content and function. Immunoglobulins have been show to be effective therapy for immune thrombocytopenia, neonatal allo(iso)immune thrombocytopenia, agammaglobulinemia, acquired immunodeficiency., premature neonates, burn patients, prophylaxis and treatment of infection in high risk and other conditions.</p>\",\"PeriodicalId\":77318,\"journal\":{\"name\":\"Pediatrie (Bucharest, Romania)\",\"volume\":\"41 1\",\"pages\":\"37-45\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatrie (Bucharest, Romania)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatrie (Bucharest, Romania)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[The indications for intravenous immunoglobulins in pediatric practice].
Current techniques allow the manufacture of intravenous immunoglobulin that fully retain their antibody content and function. Immunoglobulins have been show to be effective therapy for immune thrombocytopenia, neonatal allo(iso)immune thrombocytopenia, agammaglobulinemia, acquired immunodeficiency., premature neonates, burn patients, prophylaxis and treatment of infection in high risk and other conditions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
